Skip to main content

TAO Synergies Inc

Exchange: NASDAQSector: HealthcareIndustry: Biotechnology

TAO Synergies Inc. is the first pure-play public company dedicated to the intersection of cryptocurrency and AI, with a treasury strategy centered on acquiring, staking, and leveraging Bittensor (TAO) tokens. By providing transparent, regulated exposure to decentralized AI, TAO Synergies empowers investors to participate in the next era of technological disruption.

Did you know?

Price sits at 39% of its 52-week range.

Current Price

$5.33

+3.90%
Profile
Valuation (TTM)
Market Cap$38.00M
P/E-1.30
EV
P/B1.80
Shares Out7.13M
P/Sales127.05
Revenue$299061.00
EV/EBITDA

TAO Synergies Inc (TAOX) Financial Statements

TAOX Financial Data

EBITDA$-28.73M
Revenue (TTM)$299061.00
Gross Profit (TTM)$299061.00
Gross Margin
Operating Margin-3025.19%
ROE-136.51%
ROA-111.23%
Debt/Equity
Current Ratio13.99
FCF$-6.40M
FCF Yield-16.83%
Piotroski F-Score
Rev/Share (TTM)$0.04
50-Day MA$5.05
200-Day MA$6.07
Shares Outstanding0.01B

TAOX Computed Insights

FCF$-6.40M
FCF Growth Rate
EPS Growth (CAGR)
WACC10.00%

Income Statement

Balance Sheet

Cash Flow Statement

TAOX Financial Statements & Data

TAO Synergies Inc (TAOX) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of TAO Synergies Inc's financial performance and position as a Healthcare company.

Trailing twelve-month (TTM) revenue is $299061.00. Gross profit (TTM) is $299061.00. EBITDA is $-28.73M. Earnings per share (EPS) is $-8.81. The P/E ratio is -1.30. Market capitalization is $38.00M.

Free cash flow (FCF) is $-6.40M. Weighted average cost of capital (WACC) is 10.00%.

Historical revenue data covers 7 years from FY19 to FY25. Net income history spans 7 years. Free cash flow and capital expenditure data spans 7 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.

Use TAO Synergies Inc's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.